LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR‐744‐3p/YY1 signalling

Long non‐coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process. Here, we demonstrated that lncRNA LINC00899 was upregulated in acute myeloid leukaemia (AML) cells and was quite correlated with poor progno...

Full description

Saved in:
Bibliographic Details
Published inCell biochemistry and function Vol. 38; no. 7; pp. 955 - 964
Main Authors Dong, XueMei, Xu, Xin, Guan, YanPing
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Long non‐coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process. Here, we demonstrated that lncRNA LINC00899 was upregulated in acute myeloid leukaemia (AML) cells and was quite correlated with poor prognosis of AML patients. High expression of LINC00899 in AML cells could promote cell proliferation and inhibit cell apoptosis, and facilitate the progression of AML consequently both in vitro and in vivo. Besides, LINC00899 acted as a molecular sponge of miR‐744‐3p. Furthermore, we characterized YY1 as the direct target of miR‐744‐3p, and LINC00899/miR‐744‐3p interaction modulated YY1 expression in AML cells. Finally, we verified LINC00899 modulated AML cell proliferation and apoptosis via regulating YY1. Our study revealed novel mechanism about how did lncRNA LINC00899 execute function in AML and thus provided potential therapeutic interventions for AML. Significance of the study LncRNA LINC00899 is upregulated in AML cells and is correlated with poor prognosis of AML patients. LncRNA LINC00899 mediates cell proliferation and apoptosis of acute myeloid leukaemia cells. Knockdown of LINC00899 inhibited the growth of xenograft glioma tumour in vivo. LINC00899 acts as a molecular sponge of miR‐744‐3p. YY1 is the downstream target of LINC00899/miR‐744‐3p signalling.
AbstractList Long non‐coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process. Here, we demonstrated that lncRNA LINC00899 was upregulated in acute myeloid leukaemia (AML) cells and was quite correlated with poor prognosis of AML patients. High expression of LINC00899 in AML cells could promote cell proliferation and inhibit cell apoptosis, and facilitate the progression of AML consequently both in vitro and in vivo. Besides, LINC00899 acted as a molecular sponge of miR‐744‐3p. Furthermore, we characterized YY1 as the direct target of miR‐744‐3p, and LINC00899/miR‐744‐3p interaction modulated YY1 expression in AML cells. Finally, we verified LINC00899 modulated AML cell proliferation and apoptosis via regulating YY1. Our study revealed novel mechanism about how did lncRNA LINC00899 execute function in AML and thus provided potential therapeutic interventions for AML.Significance of the studyLncRNA LINC00899 is upregulated in AML cells and is correlated with poor prognosis of AML patients.LncRNA LINC00899 mediates cell proliferation and apoptosis of acute myeloid leukaemia cells.Knockdown of LINC00899 inhibited the growth of xenograft glioma tumour in vivo.LINC00899 acts as a molecular sponge of miR‐744‐3p.YY1 is the downstream target of LINC00899/miR‐744‐3p signalling.
Long non‐coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process. Here, we demonstrated that lncRNA LINC00899 was upregulated in acute myeloid leukaemia (AML) cells and was quite correlated with poor prognosis of AML patients. High expression of LINC00899 in AML cells could promote cell proliferation and inhibit cell apoptosis, and facilitate the progression of AML consequently both in vitro and in vivo. Besides, LINC00899 acted as a molecular sponge of miR‐744‐3p. Furthermore, we characterized YY1 as the direct target of miR‐744‐3p, and LINC00899/miR‐744‐3p interaction modulated YY1 expression in AML cells. Finally, we verified LINC00899 modulated AML cell proliferation and apoptosis via regulating YY1. Our study revealed novel mechanism about how did lncRNA LINC00899 execute function in AML and thus provided potential therapeutic interventions for AML. Significance of the study LncRNA LINC00899 is upregulated in AML cells and is correlated with poor prognosis of AML patients. LncRNA LINC00899 mediates cell proliferation and apoptosis of acute myeloid leukaemia cells. Knockdown of LINC00899 inhibited the growth of xenograft glioma tumour in vivo. LINC00899 acts as a molecular sponge of miR‐744‐3p. YY1 is the downstream target of LINC00899/miR‐744‐3p signalling.
Long non-coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process. Here, we demonstrated that lncRNA LINC00899 was upregulated in acute myeloid leukaemia (AML) cells and was quite correlated with poor prognosis of AML patients. High expression of LINC00899 in AML cells could promote cell proliferation and inhibit cell apoptosis, and facilitate the progression of AML consequently both in vitro and in vivo. Besides, LINC00899 acted as a molecular sponge of miR-744-3p. Furthermore, we characterized YY1 as the direct target of miR-744-3p, and LINC00899/miR-744-3p interaction modulated YY1 expression in AML cells. Finally, we verified LINC00899 modulated AML cell proliferation and apoptosis via regulating YY1. Our study revealed novel mechanism about how did lncRNA LINC00899 execute function in AML and thus provided potential therapeutic interventions for AML. SIGNIFICANCE OF THE STUDY: LncRNA LINC00899 is upregulated in AML cells and is correlated with poor prognosis of AML patients. LncRNA LINC00899 mediates cell proliferation and apoptosis of acute myeloid leukaemia cells. Knockdown of LINC00899 inhibited the growth of xenograft glioma tumour in vivo. LINC00899 acts as a molecular sponge of miR-744-3p. YY1 is the downstream target of LINC00899/miR-744-3p signalling.
Author Guan, YanPing
Dong, XueMei
Xu, Xin
Author_xml – sequence: 1
  givenname: XueMei
  surname: Dong
  fullname: Dong, XueMei
  organization: Gansu Provincial Maternity and Child care Hospital
– sequence: 2
  givenname: Xin
  surname: Xu
  fullname: Xu, Xin
  organization: Children's Hospital of Nanjing Medical University
– sequence: 3
  givenname: YanPing
  orcidid: 0000-0003-2594-6399
  surname: Guan
  fullname: Guan, YanPing
  email: guanypxwh@163.com
  organization: Xuanwu Hospital, Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32157707$$D View this record in MEDLINE/PubMed
BookMark eNp1kctq3DAUhkVIaCZJIU9QBN104-Tobi3TobnAkEJoFlkZWXM8KJWtqTUmzK6P0Gfsk1TTpC0UstH54Xx8SPqPyP6QBiTklMEZA-Dnvu3OhOJsj8wYWFtBLeU-mQHXotKylofkKOdHALBawBtyKDhTxoCZkbgY_N3tBV3c3M4Bamvpekx92mDehdWIOYc00NRR56cN0n6LMYUljTh9ddgHR9st7dNyim4ThhXtw93P7z-MlOUU6_OHB0ZzWA0uxrI9IQedixnfvsxjcn_56cv8ulp8vrqZXywqL6RlVYcglXDWa-WlaWXtrNYIiqmu5tLzukTu0Bq-9MwpLoX2ooQSoZVWiWPy4dlbnvBtwrxp-pA9xugGTFNuuDCacyssL-j7_9DHNI3lvoWS0hirrTL_hH5MOY_YNesx9G7cNgyaXQNNaaDZNVDQdy_Cqe1x-Rf88-UFqJ6BpxBx-6qomX-8_C38Bb-ijzI
CitedBy_id crossref_primary_10_1016_j_clinre_2022_101915
crossref_primary_10_1007_s00018_020_03646_0
crossref_primary_10_1038_s41419_022_05435_y
crossref_primary_10_3389_frnar_2024_1334464
crossref_primary_10_1002_jgm_3371
crossref_primary_10_1111_jcmm_16550
crossref_primary_10_1186_s12935_021_02069_6
crossref_primary_10_1016_j_ygeno_2020_11_019
crossref_primary_10_1016_j_biopha_2023_114807
crossref_primary_10_3390_ijms24097848
crossref_primary_10_1097_MD_0000000000031990
crossref_primary_10_1007_s40291_022_00619_w
crossref_primary_10_3892_etm_2021_10505
Cites_doi 10.3934/biophy.2015.4.794
10.2147/CMAR.S180724
10.1111/nan.12541
10.1016/j.ncrna.2018.11.004
10.18632/oncotarget.20088
10.1093/toxsci/kfw203
10.1111/exd.13888
10.1038/leu.2015.188
10.7150/thno.21740
10.7554/eLife.25607
10.1007/s40291-018-0380-6
10.1016/j.ncrna.2019.01.003
10.18632/oncotarget.6446
10.1042/BST20120020
10.1159/000485395
10.3748/wjg.v21.i17.5220
10.1182/blood-2015-10-662684
10.5808/GI.2018.16.4.e18
10.1186/s13045-019-0734-5
10.1038/leu.2017.116
10.3390/ijms18122578
10.3324/haematol.2017.171744
10.1200/JCO.2010.30.1820
10.3390/jcm4030441
10.1016/j.gene.2019.03.055
10.1186/s13045-018-0596-2
ContentType Journal Article
Copyright 2020 John Wiley & Sons Ltd
2020 John Wiley & Sons Ltd.
2020 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2020 John Wiley & Sons Ltd
– notice: 2020 John Wiley & Sons Ltd.
– notice: 2020 John Wiley & Sons, Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7TK
7TM
7U7
8FD
C1K
FR3
P64
RC3
7X8
DOI 10.1002/cbf.3521
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
Nucleic Acids Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1099-0844
EndPage 964
ExternalDocumentID 10_1002_cbf_3521
32157707
CBF3521
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
29B
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH6
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NDZJH
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RBB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
V8K
W8V
W99
WBKPD
WH7
WIB
WIH
WIJ
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WSB
WXI
WXSBR
WYISQ
XG1
XPP
XV2
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7TK
7TM
7U7
8FD
C1K
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c3491-fe0453a9c65c47b48a966e0515f824c280512ae972dc1a52436c31a5a520b4953
IEDL.DBID DR2
ISSN 0263-6484
IngestDate Sat Aug 17 01:12:21 EDT 2024
Thu Oct 10 19:47:20 EDT 2024
Fri Aug 23 02:58:01 EDT 2024
Sat Sep 28 08:45:27 EDT 2024
Sat Aug 24 01:04:41 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords YY1
LncRNA
LINC00899
acute myeloid leukaemia
miR-744-3p
Language English
License 2020 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3491-fe0453a9c65c47b48a966e0515f824c280512ae972dc1a52436c31a5a520b4953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2594-6399
PMID 32157707
PQID 2447796957
PQPubID 2029981
PageCount 10
ParticipantIDs proquest_miscellaneous_2376229392
proquest_journals_2447796957
crossref_primary_10_1002_cbf_3521
pubmed_primary_32157707
wiley_primary_10_1002_cbf_3521_CBF3521
PublicationCentury 2000
PublicationDate October 2020
2020-Oct
2020-10-00
20201001
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: October 2020
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bognor Regis
PublicationTitle Cell biochemistry and function
PublicationTitleAlternate Cell Biochem Funct
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 2
2017; 6
2017; 8
2019; 4
2015; 4
2019; 707
2019; 11
2017; 44
2019; 12
2016; 30
2016; 127
2017; 155
2018; 22
2017; 31
2016; 7
2018; 8
2018; 3
2019; 23
2019; 45
2015; 21
2019; 28
2016; 132
2017; 18
2018; 11
2018; 32
2017; 102
2011; 29
2018; 16
2012; 40
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
Wang Y (e_1_2_8_29_1) 2018; 22
e_1_2_8_3_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
Tremblay D (e_1_2_8_7_1) 2018; 32
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
Järvenpää J (e_1_2_8_2_1) 2016; 132
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
Sun M (e_1_2_8_27_1) 2018; 22
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_30_1
References_xml – volume: 31
  start-page: 2543
  issue: 12
  year: 2017
  end-page: 2551
  article-title: Dysfunction of the WT1‐MEG3 signaling promotes AML leukemogenesis via p53‐dependent and ‐independent pathways
  publication-title: Leukemia
– volume: 18
  issue: 12
  year: 2017
  article-title: Long non‐coding RNAs in metabolic organs and energy homeostasis
  publication-title: Int J Mol Sci
– volume: 22
  start-page: 2233
  year: 2018
  end-page: 2245
  article-title: Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR‐126
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 132
  start-page: 1465
  issue: 16
  year: 2016
  end-page: 1473
  article-title: Treatment of adult acute myeloid leukemia
  publication-title: Duodecim
– volume: 30
  start-page: 24
  issue: 1
  year: 2016
  end-page: 31
  article-title: Treatment, trial participation and survival in adult acute myeloid leukemia: a population‐based study in the Netherlands, 1989‐2012
  publication-title: Leukemia
– volume: 6
  year: 2017
  article-title: lncRNA requirements for mouse acute myeloid leukemia and normal differentiation
  publication-title: Elife
– volume: 32
  start-page: e38
  issue: 4
  year: 2018
  end-page: e44
  article-title: Implications of mutation profiling in myeloid malignancies. Part 1: Myelodysplastic syndromes and acute myeloid leukemia
  publication-title: Oncology (Williston Park)
– volume: 11
  start-page: 3197
  year: 2019
  end-page: 3213
  article-title: Evaluating venetoclax and its potential in treatment‐naive acute myeloid leukemia
  publication-title: Cancer Manag Res
– volume: 7
  start-page: 5226
  issue: 5
  year: 2016
  end-page: 5239
  article-title: Long non‐coding RNAs in colorectal cancer
  publication-title: Oncotarget
– volume: 22
  start-page: 7364
  issue: 21
  year: 2018
  end-page: 7370
  article-title: Long non‐coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 12
  start-page: 51
  issue: 1
  year: 2019
  article-title: Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
  publication-title: J Hematol Oncol
– volume: 2
  start-page: 794
  issue: 4
  year: 2015
  end-page: 809
  article-title: The interplay of long non‐coding RNAs and MYC in cancer
  publication-title: AIMS Biophys
– volume: 8
  start-page: 1084
  issue: 4
  year: 2018
  end-page: 1105
  article-title: PIWIL3/OIP5‐AS1/miR‐367‐3p/CEBPA feedback loop regulates the biological behavior of glioma cells
  publication-title: Theranostics
– volume: 155
  start-page: 3
  issue: 1
  year: 2017
  end-page: 21
  article-title: Long non‐coding RNAs: a novel paradigm for toxicology
  publication-title: Toxicol Sci
– volume: 11
  start-page: 52
  issue: 1
  year: 2018
  article-title: Expression levels of long non‐coding RNAs are prognostic for AML outcome
  publication-title: J Hematol Oncol
– volume: 127
  start-page: 1
  issue: 1
  year: 2016
  article-title: Introduction to the review series on advances in acute myeloid leukemia (AML)
  publication-title: Blood
– volume: 23
  start-page: 155
  issue: 2
  year: 2019
  end-page: 171
  article-title: MicroRNAs and long non‐coding RNAs in genetic diseases
  publication-title: Mol Diagn Ther
– volume: 45
  start-page: 538
  year: 2019
  end-page: 556
  article-title: Review: Long non‐coding RNAs: important regulators in the development, function and disorders of the central nervous system
  publication-title: Neuropathol Appl Neurobiol
– volume: 4
  start-page: 36
  issue: 1
  year: 2019
  end-page: 44
  article-title: Long non‐coding RNAs: Functional regulatory players in breast cancer
  publication-title: Noncoding RNA Res
– volume: 29
  start-page: 487
  issue: 5
  year: 2011
  end-page: 494
  article-title: Therapeutic advances in acute myeloid leukemia
  publication-title: J Clin Oncol
– volume: 16
  issue: 4
  year: 2018
  article-title: Roles of oncogenic long non‐coding RNAs in cancer development
  publication-title: Genomics Inform
– volume: 21
  start-page: 5220
  issue: 17
  year: 2015
  end-page: 5230
  article-title: Roles of long non‐coding RNAs in gastric cancer metastasis
  publication-title: World J Gastroenterol
– volume: 102
  start-page: 1301
  issue: 8
  year: 2017
  end-page: 1303
  article-title: Long non‐coding RNAs: another brick in the wall of normal karyotype acute myeloid leukemia?
  publication-title: Haematologica
– volume: 40
  start-page: 902
  issue: 4
  year: 2012
  end-page: 906
  article-title: Long non‐coding RNAs and human disease
  publication-title: Biochem Soc Trans
– volume: 3
  start-page: 226
  issue: 4
  year: 2018
  end-page: 231
  article-title: Long noncoding RNAs and ALS: still much to do
  publication-title: Noncoding RNA Res
– volume: 28
  start-page: 283
  issue: 3
  year: 2019
  end-page: 291
  article-title: MiR‐744‐3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis
  publication-title: Exp Dermatol
– volume: 44
  start-page: 948
  issue: 3
  year: 2017
  end-page: 966
  article-title: Long non‐coding RNAs: the New Horizon of gene regulation in ovarian cancer
  publication-title: Cell Physiol Biochem
– volume: 8
  start-page: 69174
  issue: 40
  year: 2017
  end-page: 69184
  article-title: Long non‐coding RNAs associated with non‐small cell lung cancer
  publication-title: Oncotarget
– volume: 707
  start-page: 172
  year: 2019
  end-page: 177
  article-title: The prognostic significance of the long non‐coding RNAs "CCAT1, PVT1" in t(8;21) associated acute myeloid leukemia
  publication-title: Gene
– volume: 4
  start-page: 441
  issue: 3
  year: 2015
  end-page: 459
  article-title: Treatment of acute myeloid leukemia in adolescent and young adult patients
  publication-title: J Clin Med
– ident: e_1_2_8_15_1
  doi: 10.3934/biophy.2015.4.794
– ident: e_1_2_8_6_1
  doi: 10.2147/CMAR.S180724
– ident: e_1_2_8_12_1
  doi: 10.1111/nan.12541
– ident: e_1_2_8_13_1
  doi: 10.1016/j.ncrna.2018.11.004
– ident: e_1_2_8_21_1
  doi: 10.18632/oncotarget.20088
– ident: e_1_2_8_28_1
  doi: 10.1093/toxsci/kfw203
– ident: e_1_2_8_31_1
  doi: 10.1111/exd.13888
– ident: e_1_2_8_3_1
  doi: 10.1038/leu.2015.188
– ident: e_1_2_8_30_1
  doi: 10.7150/thno.21740
– ident: e_1_2_8_24_1
  doi: 10.7554/eLife.25607
– ident: e_1_2_8_10_1
  doi: 10.1007/s40291-018-0380-6
– ident: e_1_2_8_17_1
  doi: 10.1016/j.ncrna.2019.01.003
– ident: e_1_2_8_18_1
  doi: 10.18632/oncotarget.6446
– ident: e_1_2_8_16_1
  doi: 10.1042/BST20120020
– volume: 32
  start-page: e38
  issue: 4
  year: 2018
  ident: e_1_2_8_7_1
  article-title: Implications of mutation profiling in myeloid malignancies. Part 1: Myelodysplastic syndromes and acute myeloid leukemia
  publication-title: Oncology (Williston Park)
  contributor:
    fullname: Tremblay D
– ident: e_1_2_8_19_1
  doi: 10.1159/000485395
– ident: e_1_2_8_20_1
  doi: 10.3748/wjg.v21.i17.5220
– ident: e_1_2_8_8_1
  doi: 10.1182/blood-2015-10-662684
– ident: e_1_2_8_11_1
  doi: 10.5808/GI.2018.16.4.e18
– ident: e_1_2_8_5_1
  doi: 10.1186/s13045-019-0734-5
– ident: e_1_2_8_26_1
  doi: 10.1038/leu.2017.116
– ident: e_1_2_8_14_1
  doi: 10.3390/ijms18122578
– ident: e_1_2_8_23_1
  doi: 10.3324/haematol.2017.171744
– volume: 22
  start-page: 2233
  year: 2018
  ident: e_1_2_8_27_1
  article-title: Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR‐126
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Sun M
– ident: e_1_2_8_9_1
  doi: 10.1200/JCO.2010.30.1820
– ident: e_1_2_8_4_1
  doi: 10.3390/jcm4030441
– volume: 132
  start-page: 1465
  issue: 16
  year: 2016
  ident: e_1_2_8_2_1
  article-title: Treatment of adult acute myeloid leukemia
  publication-title: Duodecim
  contributor:
    fullname: Järvenpää J
– ident: e_1_2_8_22_1
  doi: 10.1016/j.gene.2019.03.055
– volume: 22
  start-page: 7364
  issue: 21
  year: 2018
  ident: e_1_2_8_29_1
  article-title: Long non‐coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Wang Y
– ident: e_1_2_8_25_1
  doi: 10.1186/s13045-018-0596-2
SSID ssj0009630
Score 2.355069
Snippet Long non‐coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process....
Long non-coding RNA (lncRNA) LINC00899 is one kind cytoplasmic lncRNA, however, there is rarely little information about its function in physiological process....
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 955
SubjectTerms 3' Untranslated Regions
acute myeloid leukaemia
Acute myeloid leukemia
Animals
Antagomirs - metabolism
Apoptosis
Cell growth
Cell Line, Tumor
Cell Proliferation
Disease Progression
Glioma
Humans
Kaplan-Meier Estimate
Leukemia
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - mortality
Leukemia, Myeloid, Acute - pathology
LINC00899
LncRNA
Mice
Mice, Nude
MicroRNAs - metabolism
miR‐744‐3p
Non-coding RNA
Prognosis
Ribonucleic acid
RNA
RNA Interference
RNA, Long Noncoding - antagonists & inhibitors
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
RNA, Small Interfering - metabolism
RNA, Small Interfering - therapeutic use
Signal Transduction
Signaling
Therapeutic applications
Tumors
Up-Regulation
Xenografts
Xenotransplantation
YY1
YY1 Transcription Factor - chemistry
YY1 Transcription Factor - genetics
YY1 Transcription Factor - metabolism
Title LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR‐744‐3p/YY1 signalling
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbf.3521
https://www.ncbi.nlm.nih.gov/pubmed/32157707
https://www.proquest.com/docview/2447796957
https://search.proquest.com/docview/2376229392
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9swGLYQEmKXjbGvbgx50rRb2vgjdnNkHRVCwKEaEmiHyJ8I0SbV2hy6037CfuN-yV47SRFMSIhLYil2nPj1x2P78fMi9BnGJA3dPiA3ImzCHbFBA5IkWiimSW4NdeGg8OmZODrnxxfZRcuqDGdhGn2I9YJbaBmxvw4NXOnF4FY01GjfB_QQZj6EycDm-ja5VY6CetUur7BE8CHvdGdTOugS3h2J_oOXd9FqHG7GL9CP7kMblslNv17qvvl1T8PxaX-yg563KBQfNNXmJdpw5S7aavxSrnbR9qhzA_cKTU9KMzk7wCcw_U_D7h2eRwafW-DI7Wp0PXDlsTL10uHZyk2ra4unrr5R8BaF9QrPKhvdhJVXeHY9-fv7j-Qcrmw-uLwkOHBIVNQGf43Ox4ffR0dJ66IhMYznJPEOICFTuRGZ4VLzoQJLu-A3xg8pN3QIQapcLqk1RGWUM2EYBCCY6kBtfYM2y6p07xC2TInUGkekzbiHiZtnQjtmvaJeeS966FNnrmLeKHEUjeYyLaAEi1CCPbTX2bFo2-KiAAAjZS7yTMIr1o-hFMPWiCpdVUMc6GcpIJ-c9tDbxv7rTBigIilTSP0lWvHB3IvR13G4v39sxA_oGQ3T98gN3EOby5-1-wgYZ6n3Y23-B9eL9n4
link.rule.ids 315,783,787,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFD6ahtC4GWP8rDDASIi7tIntOI24GoWqQNeLapM2CSnyL5rWJhVrLsoVj8Az8iQ7dppOAyEhbhJLsePE5xz7s338HYDXOCYp7PYRuSXCRNwmxnNAJpESkqkkN5paf1D4eCJGp_zTWXq2BW_bszANP8Rmwc1bRuivvYH7BeneDWuoVq6L8AGnPnfQ2pkPX_B-esMdhZq1XmBhkeB93jLPxrTXlrw9Fv0BMG_j1TDgDO_Dl_ZTGz-Ty269VF39_TcWx__8lz3YXQNRctRozgPYsuU-3G1CU672YWfQRoJ7CLNxqaeTIzL-OBnEfgOPLIITn70iwb2rofYglSNS10tL5is7qy4Mmdn6UuJbJFErMq9MiBRWfiXzi-mvHz8zzvHKFr3z84R4NxIZ6MEfwenww8lgFK2jNESa8TyJnEVUyGSuRap5pnhforCtDx3j-pRr2scklTbPqNGJTClnQjNMYDJW3rv1MWyXVWkPgBgmRWy0TTKTcodzN8eEssw4SZ10TnTgVSuvYtGQcRQN7TItsAUL34IdOGwFWazN8apADJNlucjTDF-xeYyt6HdHZGmrGvNgV0sR_OS0A08aBdhUwhAYZVmMpd8EMf619mLwbujvT_8140vYGZ0cjwuU4OdncI_62XxwFTyE7eW32j5HyLNUL4JqXwM5nfqY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL1CRTw2PAqFgQJGQuwyk9iOPVmWKaMKSoVGVGrFIvITVZ1JRnSyGFZ8At_Il3DtJFMVhITYJJZix4mvH8f28bkAr3BM0tjtI3LLhE24y2zQgMwSLRTTWWENdeGg8IcjcXDM353kJx2rMpyFafUhNgtuoWXE_jo08KX1o0vRUKP9ENEDznyuc8HSQOfan11KR2HF6tZXWCL4mPfCsykd9SmvDkV_4MurcDWON9O78Ln_0pZmcj5sVnpovv0m4vh_v3IP7nQwlOy19eY-XHPVNtxoHVOut-HWpPcD9wDmh5WZHe2RQ5z_p2H7jiwjhc9dkEjuaoU9SO2JMs3KkcXazeszS-auOVf4FkX0mixqG_2EVV_I4mz28_sPyTle2XJ0epqRQCJRURz8IRxP336aHCSdj4bEMF5kiXeICZkqjMgNl5qPFZraBccxfky5oWMMUuUKSa3JVE45E4ZhAIOpDtzWHdiq6so9BmKZEqk1LpM25x5nbp4J7Zj1inrlvRjAy95c5bKV4ihb0WVaYgmWoQQHsNvbsewa40WJCEbKQhS5xFdsHmMphr0RVbm6wTjY0VKEPgUdwKPW_ptMGMIiKVNM_Tpa8a-5l5M303B_8q8RX8DNj_vTEg34_incpmEqH3mCu7C1-tq4Z4h3Vvp5rNi_AFFn-Uc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNA+LINC00899+promotes+progression+of+acute+myeloid+leukaemia+by+modulating+miR-744-3p%2FYY1+signalling&rft.jtitle=Cell+biochemistry+and+function&rft.au=Dong%2C+XueMei&rft.au=Xu%2C+Xin&rft.au=Guan%2C+YanPing&rft.date=2020-10-01&rft.eissn=1099-0844&rft.volume=38&rft.issue=7&rft.spage=955&rft_id=info:doi/10.1002%2Fcbf.3521&rft_id=info%3Apmid%2F32157707&rft.externalDocID=32157707
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0263-6484&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0263-6484&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0263-6484&client=summon